Long-term survival in a patient with recurrent nasopharyngeal carcinoma treated with capecitabine

Pediatr Blood Cancer. 2022 Jul;69(7):e29605. doi: 10.1002/pbc.29605. Epub 2022 Feb 21.

Authors

Sanaa Ayyoub¹, Iyad Sultan²

Affiliations

¹ Endocrinology Department, Dartmouth Hitchcock Medical Center, Manchester, New Hampshire, USA.
² Department of Pediatric Oncology, King Hussein Cancer Center, Amman, Jordan.

PMID: 35187809
DOI: 10.1002/pbc.29605

No abstract available

Publication types

Letter

MeSH terms

Capecitabine
Fluorouracil
Humans
Nasopharyngeal Carcinoma / drug therapy
Nasopharyngeal Carcinoma / pathology
Nasopharyngeal Neoplasms* / pathology
Neoplasm Recurrence, Local* / drug therapy

Substances

Capecitabine
Fluorouracil